Strides Arcolab soars on striking in-licensing deal

DALAL STREET SPIKES

Under the agreement, OTL will license intellectual property and supply finished dosage form pharmaceuticals to GSK. OTL will recover the intellectual property development costs from and share the profits with GSK. The stock hit a high of Rs 179.80 and a low of Rs 144.